Harbin Medisan Pharmaceutical: Announcement on the Progress of Providing Guarantees to Wholly-owned Subsidiaries.
Harbin Medisan Pharmaceutical: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Harbin Medisan Pharmaceutical: Legal Opinion of the 2023 Annual General Meeting of Shareholders
Harbin Medisan Pharmaceutical: Internal Control Self-Assessment Report
Harbin Medisan Pharmaceutical: Report of the Audit Committee of the Board of Directors on the performance of supervisory duties by accounting firms in 2023
Harbin Medisan Pharmaceutical: Notice on applying for comprehensive credit lines from banks and other financial institutions and providing guarantees for wholly-owned subsidiaries in 2024
Harbin Medisan Pharmaceutical: 2023 Financial Results Report
Harbin Medisan Pharmaceutical: Special instructions for securities investment
Harbin Medisan Pharmaceutical: 2024 Remuneration Plan for Directors, Supervisors and Senior Management
Harbin Medisan Pharmaceutical: Notice of Annual General Meeting of Shareholders
Kazakh Sanlian: Announcement on the name change of the sponsor agency and the change of the sponsor representative for continuous supervision
Kazakh Sanlian: Notice on Wholly-owned Subsidiaries Changing Legal Representatives and Completing Registration of Industrial and Commercial Changes
Kazakhstan Sanlian: Progress announcement on providing guarantees for wholly-owned subsidiaries
Kazakh Sanlian: Notice on Wholly-owned Subsidiaries Changing Registered Capital and Completing the Registration of Industrial and Commercial Changes
Kazakh Sanlian: Announcement on the Company and Wholly Owned Subsidiaries Receiving Government Subsidies
Kazakhstan Sanlian: Progress announcement on providing guarantees for wholly-owned subsidiaries
Kazakh Sanlian: Announcement on completing registration of changes in registered capital and issuing business licenses
Kazakh Triptych: Legal Opinion of the Fifth Extraordinary General Meeting of Shareholders in 2023
Kazakh Triptych: Announcement of Resolutions of the Fifth Extraordinary General Meeting of Shareholders in 2023
Kazakh Triptych: Comparative table of revisions to the company\'s articles of association
No Data